Диссертация (1140051), страница 14
Текст из файла (страница 14)
Penta [et al.] // J Exp Clin Cancer Res. – 2005. – Vol. 24(3). – P. 337-45.116. Pita-Gutierrez, F. Place of preoperative treatment of acromegaly withsomatostatin analog on surgical outcome: a systematic review and metaanalysis /F. Pita-Gutierrez [et al.] // PLoS One. – 2013. – № 8(4). – Р. e61523.117. Rajasoorya, C. Determinants of clinical outcome and survivial in acromegaly / C.Rajasoorya [et al.] // Clin Endocrinol (Oxf). – 1994.
– № 41(1). – Р. 95-102.118. Ramos-Leví, A.M. Cardiovascular comorbidities in acromegaly: an update ontheir diagnosis and management / A.M. Ramos-Leví [et al.] // Endocrine. – 2017.– № 55(2). – Р. 346-359.119. Ritvonen, E. Mortality in acromegaly: a 20-year follow-up study / E. Ritvonen [etal.] // Endocr Relat Cancer. – 2015. – № (6). – Р. 469-480.120. Rokkas, T. Risk of colorectal neoplasm 42 in patients with acromegaly: a metaanalysis / T. Rokkas [et al.] // World J Gastroenterol. – 2008. – № 14.
– Р. 34843489.121. Ron, E. Jr. Acromegaly and gastrointestinal cancer / E. Ron [et al.] // Cancer. –1991. – № 68(8). – Р. 1673-1677.122. Schlemper, R.J. Review of histological classifications of gastrointestinalepithelial neoplasia: differences in diagnosis of early carcinomas betweenJapanese and Western pathologists / R.J. Schlemper [et al.] // J.
Gastroenterol. –2001. – Vol. 36, № 7. – P. 445-456.123. Sherlock, M. Mortality in patients with pituitary disease / M. Sherlock, J. Ayuk,J.W. Tomlinson [et al.] // Endocr Rev. – 2010. – № 31(3). Р. 301-342.124. Solomon, Т.Е. Comparative potencies of cholecystokinin and gastrin for gastricand pancreatic secretion in dogs / Т.Е.
Solomon [et al.] // Gastroenterology. –1984. – Vol. 86. – P. 1260.125. Stolte, M. Differentiation of focal foveolar hyperplasia from hyperplastic polypsin gastric biopsy material / М. Stolte [et al.] // Pathol. Res. Pract. – 1995. – №191. – P. 1198-1202.94126. Strand, S. Cleavage of CD95 by matrix metalloproteinase-7 induces apoptosisresistance in tumour cells / S. Strand [et al.] // Oncogene. – 2004. – Vol. 23. – P.3732-3736.127. Sugano, K.
Kyoto global consensus report on Helicobacter pylori gastritis / K.Sugano [et al.] // Gut. – 2015. – № 64(9). – Р. 1353-1367.128. Testino, G. Gastric preneoplastic changes / G. Testino // Recenti. Prog. Med. –2004. – Vol. 95. – P. 239-244.129. Van der Klaauw, A.A. Increased aortic root diameters in patients withacromegaly / А.А. Van der Klaauw [et al.] // European journal of endocrinology.– 2008. – Vol.
159, № 2. – Р. 97-103.130. Vasen, H.F. Increased prevalence of colonic adenomas in patients withacromegaly / H.F. Vasen [et al.] // Eur J Endocrinol. – 1994. – Vol. 131. – P.235-237.131. Warren, J.R. Unidentified curved bacilli in the stomach of patients with gastritisand peptic ulceration / J.R. Warren, B.J. Marshall // Lancet. – 1983. – № 1.
– Р.1311-1315.132. Wassenaar, M.J. Acromegaly is associated with an increased prevalence ofcolonic diverticula: a case-control study / M.J. Wassenaar [et al.] // J ClinEndocrinol Metab. – 2010. – № 95(5). – Р. 2073-2079.133. Webb, S.M. Oncological complications of excess GH in acromegaly / S.B. Webb[et al.] // Pituitary. – 2002. – Vol. 5(1).
– P. 21-25.134. Wilson, C.L. Intestinal tumorigenesis is suppressed in mice lacking themetalloproteinase matrilysin / C.L. Wilson [et al.] // Proc. Natl. Acad. Sci. USA.– 1997. – № 94. – P. 1402-1407.135. Wright, A.D. Mortality in acromegaly / A.D. Wright, D.M. Hill, C. Lowy, T.R.Fraser // Q J Med. – 1970. – № 39(153).
– Р. 1-16.136. Yao, K. Magnifying endoscopy for diagnosing and delineating early gastriccancer / K. Yao [et al.] // Endoscopy. – 2009. – Vol. 41, № 5. – P. 462-467.95137. Zhang, C.L. Changes in patients’ symptoms and gastric emptying afterHelicobacter pylori treatment / C.L. Zhang [et al.] // World J Gastroenterol. –2016. – № 22(18). – Р. 4585-4593..
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
